Amy Welsh
Corporate Officer/Principal bij AGILE THERAPEUTICS, INC.
Vermogen: 5 400 $ op 30-04-2024
Actieve functies van Amy Welsh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| AGILE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-11-2022 | - |
| Verkoop & Marketing | 01-05-2020 | 01-11-2022 |
Loopbaan van Amy Welsh
Eerdere bekende functies van Amy Welsh
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ANTARES PHARMA, INC. | Verkoop & Marketing | 01-06-2017 | 01-05-2020 |
Opleiding van Amy Welsh
| LaSalle University | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Sales & Marketing | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| AGILE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Antares Pharma, Inc.
 Antares Pharma, Inc. Pharmaceuticals: MajorHealth Technology Antares Pharma, Inc. is a specialty pharmaceutical company, which engages in the development and commercialization of pharmaceutical products and technologies in targeted therapeutic areas. Its products include XYOSTED injection, OTREXUP injection for subcutaneous use, and Sumatriptan injection. The company was founded in February 1979 and is headquartered in Ewing, NJ. | Health Technology |